Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001331826 | SCV000830158 | uncertain significance | Mosaic variegated aneuploidy syndrome 1 | 2024-02-29 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 648 of the BUB1B protein (p.Thr648Ile). This variant is present in population databases (rs148348158, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with BUB1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 578374). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001331826 | SCV001523953 | uncertain significance | Mosaic variegated aneuploidy syndrome 1 | 2019-11-20 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Fulgent Genetics, |
RCV002477614 | SCV002793427 | uncertain significance | Mosaic variegated aneuploidy syndrome 1; Premature chromatid separation trait; Colorectal cancer | 2024-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002533619 | SCV003756948 | uncertain significance | Inborn genetic diseases | 2021-07-28 | criteria provided, single submitter | clinical testing | The c.1943C>T (p.T648I) alteration is located in exon 15 (coding exon 15) of the BUB1B gene. This alteration results from a C to T substitution at nucleotide position 1943, causing the threonine (T) at amino acid position 648 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004692168 | SCV005193703 | uncertain significance | not provided | criteria provided, single submitter | not provided |